Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response
Justine Sitz1,2,3, Sophie Anne Blanchet1,2,3, Steven F Gameiro4,5,6
1Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, QC, Canada G1R 1S3.
Abstract:
High-risk human papillomaviruses (HR-HPVs) promote cervical cancer as well as a subset of anogenital and head and neck cancers. Due to their limited coding capacity, HPVs hijack the host cell's DNA replication and repair machineries to replicate their own genomes. How this host-pathogen interaction contributes to genomic instability is unknown. Here, we report that HPV-infected cancer cells express high levels of RNF168, an E3 ubiquitin ligase that is critical for proper DNA repair following DNA double-strand breaks, and accumulate high numbers of 53BP1 nuclear bodies, a marker of genomic instability induced by replication stress. We describe a mechanism by which HPV E7 subverts the function of RNF168 at DNA double-strand breaks, providing a rationale for increased homology-directed recombination in E6/E7-expressing cervical cancer cells. By targeting a new regulatory domain of RNF168, E7 binds directly to the E3 ligase without affecting its enzymatic activity. As RNF168 knockdown impairs viral genome amplification in differentiated keratinocytes, we propose that E7 hijacks the E3 ligase to promote the viral replicative cycle. This study reveals a mechanism by which tumor viruses reshape the cellular response to DNA damage by manipulating RNF168-dependent ubiquitin signaling. Importantly, our findings reveal a pathway by which HPV may promote the genomic instability that drives oncogenesis.
Insights
High-risk human papillomaviruses (HR-HPVs) hijack the RNF168 protein to promote viral replication and genomic instability, contributing to cancer development. This interaction reshapes cellular DNA repair pathways, driving oncogenesis.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- High-risk human papillomaviruses (HR-HPVs) are oncogenic, causing various cancers by exploiting host cell machinery.
- The mechanisms by which HR-HPVs induce genomic instability and contribute to cancer remain incompletely understood.
Purpose of the Study:
- To elucidate the role of RNF168, a DNA repair E3 ubiquitin ligase, in HR-HPV infection and oncogenesis.
- To investigate how HPV E7 protein interacts with RNF168 and influences DNA damage response pathways.
Main Methods:
- Analysis of RNF168 and 53BP1 nuclear body levels in HPV-infected cancer cells.
- Investigation of HPV E7's interaction with RNF168 using biochemical assays.
- Assessment of RNF168's role in viral genome amplification via knockdown experiments.
Main Results:
- HPV-infected cells exhibit elevated RNF168 and 53BP1 nuclear bodies, indicating genomic instability.
- HPV E7 directly binds to a regulatory domain of RNF168 without altering its enzymatic activity.
- RNF168 knockdown inhibits HR-HPV genome amplification in keratinocytes.
Conclusions:
- HPV E7 subverts RNF168 function to promote viral replication and genomic instability.
- This manipulation of RNF168-dependent ubiquitin signaling by HR-HPVs contributes to oncogenesis.
- Targeting this host-pathogen interaction could offer novel therapeutic strategies for HPV-driven cancers.
Related Concept Videos
08:41Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
10:24Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:44Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:28Imaging Mismatch Repair and Cellular Responses to DNA Damage in Bacillus subtilis
05:18Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
10:59CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells

